New data from telisotuzumab adizutecan (Temab-A) and ABBV-706 across pancreatic, colorectal, and solid tumors, highlight progress in AbbVie's growing ADC portfolio designed to target...

The leading expert in alternative equity solutions for the skilled trades will share insights and best practices to support employee retention LAS VEGAS, Oct. 13, 2025 /PRNewswire/ -- Reins, a...

Pooled analysis supports the rationale for the ongoing MAIA-ovarian trial evaluating COM701 as maintenance therapy in the earlier setting of platinum sensitive ovarian cancer HOLON, Israel, Oct....

Protecting the U.S. Military's NGSW Program with Mission-Ready Protective Transit Solutions TORRANCE, Calif., Oct. 13, 2025 /PRNewswire/ -- Pelican Products, Inc, the global leader in...

Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced that the Company will participate in two upcoming healthcare conferences in November 2025. The Company will participate in...